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Abstract. 
 
Double-stranded RNA adenosine deaminase 
(ADAR1, dsRAD, DRADA) converts adenosines to 
inosines in double-stranded RNAs. Few candidate sub-
strates for ADAR1 editing are known at this point and 
it is not known how substrate recognition is achieved. 
In some cases editing sites are defined by basepaired 
regions formed between intronic and exonic sequences, 
suggesting that the enzyme might function cotranscrip-
 
tionally. We have isolated two variants of 
 
Xenopus lae-
vis
 
 ADAR1 for which no editing substrates are cur-
rently known. We demonstrate that both variants of the 
enzyme are associated with transcriptionally active 
chromosome loops suggesting that the enzyme acts 
cotranscriptionally. The widespread distribution of the 
protein along the entire chromosome indicates that 
ADAR1 associates with the RNP matrix in a substrate-
independent manner. Inhibition of splicing, another 
cotranscriptional process, does not affect the chromo-
somal localization of ADAR1. Furthermore, we can 
show that the enzyme is dramatically enriched on a spe-
cial RNA-containing loop that seems transcriptionally 
silent. Detailed analysis of this loop suggests that it 
might represent a site of ADAR1 storage or a site 
where active RNA editing is taking place. Finally, mu-
tational analysis of ADAR1 demonstrates that a puta-
tive Z-DNA binding domain present in ADAR1 is not 
required for chromosomal targeting of the protein.
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D
 
OUBLE
 
-
 
STRANDED
 
 RNA adenosine deaminase
(ADAR1, dsRAD, DRADA)
 
1
 
 is an RNA-editing
enzyme that converts adenosines to inosines by
hydrolytic deamination in double-stranded RNA (Polson
et al., 1991). The enzymatic activity was first discovered in
 
Xenopus
 
 embryos and was described as an unwinding and
modifying activity that converts adenosines to inosines in
double-stranded RNAs injected into embryos (Bass and
Weintraub, 1987; Rebagliati and Melton, 1987). Since
then, the enzymatic activity has been detected in all meta-
zoan tissues tested (for review see Bass, 1997; OÕConnell,
1997). Recently, cDNAs encoding ADAR1 have been
cloned from several organisms, including human, rat, and
 
Xenopus 
 
(Kim et al., 1994; OÕConnell et al., 1995; Hough
and Bass, 1997).
The putative translation products of the cloned cDNAs
from these organisms encode proteins in the range of 130Ð
150 kD and share several characteristic features. In gen-
eral, the COOH-terminal ends of ADAR1 proteins from
these species are more homologous to each other than
their NH
 
2
 
-terminal ends. Consistent with the high degree
of conservation, a conserved catalytic domain required for
deamination is found at the COOH-terminal end of all
ADAR1 homologues (Kim et al., 1994; Hough and Bass,
1997). Three double-stranded RNA-binding domains
(dsRBDs) are located in the central region while one or
two putative nuclear localization signals (NLS) are located
more NH
 
2
 
-terminally (St Johnston et al., 1992). Addition-
ally, some ADAR1 proteins contain a variable number of
a tandemly arranged oligopeptide motif at their NH
 
2
 
-ter-
minal ends and a short protein motif that has been imple-
mented in Z-DNA binding (Herbert et al., 1997).
The search for RNA adenosine deaminases has also led
to the identification of related proteins like RED1 (for
RNA-editing deaminase), which has recently been re-
named to ADAR2 (Melcher
 
 
 
et al., 1996; Bass
 
 
 
et al., 1997).
ADAR2 proteins are generally smaller than ADAR1 but
are quite similar in their molecular architecture. The
COOH-terminal regions contain conserved deamination
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1. 
 
Abbreviations used in this paper:
 
 AMD, actinomycin D; dsRNA, dou-
ble-stranded RNA; dsRBD, double-stranded RNA-binding domain; GV,
germinal vesicle; LBC, lampbrush chromosome; RNP, ribonucleoprotein
particle; snRNA, small nuclear RNA; SLL, sequentially labeling loop. 
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domains whereas the central region usually contains one
or two dsRBDs. In contrast, the NH
 
2
 
-terminal region is
shorter in ADAR2 and related proteins than in ADAR1
(for review see OÕConnell, 1997).
A number of candidate substrates are currently known
for editing by ADARs. These include the genomes of
some RNA viruses, several subunits of the group of
glutamate gated ion channels and the serotonin receptor
2C (Sommer
 
 
 
et al., 1991; Lomeli et al., 1994; Hurst
 
 
 
et al.,
1995; Polson et al.,
 
 
 
1996; Burns et al., 1997; reviewed by
Bass, 1997). Editing by ADAR-like enzymes leads to con-
version of an adenosine to an inosine. As inosines are in-
terpreted as guanosines by the translational machinery,
the editing event may lead to the alteration of a codon and
thus change the coding potential of the edited RNA. Inter-
estingly, RNA editing by ADARs can be quite different
depending on the substrate. In the case of measles virus or
the 
 
Drosophila 
 
4f-rnp RNA, for instance, multiple edit-
ing events occur quite randomly (Cattaneo et al., 1988;
Petschek et al., 1997). However, careful in vitro analysis
revealed that ADAR1 exhibits a 5
 
9
 
 next neighbor prefer-
ence for RNA editing (Polson and Bass, 1994). On the
other hand, editing of glutamate receptor subunits is quite
specific. In GluR-B RNA, editing occurs preferentially at
three different sites. Two of these sites are located in ex-
ons 11 and 13, respectively, and editing at these sites leads
to a change of the coding potential of the two affected
codons. Consistent with the observed codon change the
two sites are termed Q/R and R/G sites, respectively. A
third site, located in intron 11, does not affect the coding
potential of the mRNA (Sommer et al., 1991; Lomeli et al.,
1994).
Although it is not proven which enzyme is required for
the editing of these three sites in vivo, in vitro studies show
that ADAR2 (RED1) can edit both the Q/R and R/G sites
efficiently while the cryptic intronic site is edited ineffi-
ciently (Melcher et al., 1996; OÕConnell et al., 1997). In
contrast, ADAR1 can edit the R/G site and the intronic
site but shows little editing activity at the Q/R site (Hurst
et al., 1995; Dabiri et al., 1996). Similar data has been ob-
tained for the serotonin 2C receptor which is edited at a
total of four sites. Three of these sites seem to be edited by
ADAR1 while one site seems to be preferentially edited
by ADAR2 (Burns et al., 1997). These data suggest that
different ADARs might perform site-specific RNA edit-
ing in vivo.
In mRNAs encoding glutamate receptor subunits and
serotonin receptor 2C, sites of editing are apparently de-
fined by base-pairing between an exonic and an adjacent
intronic sequence (Higuchi et al., 1993; Lomeli et al., 1994;
Yang et al., 1995; Burns et al., 1997). The formed double-
stranded regions are relatively short and it has been sug-
gested that the degree of editing at these sites is limited by
the instability of the base-paired region that increases, as
editing progresses and base-pairing is inhibited by the
presence of inosines (Bass, 1997). Nonetheless, the finding
that intronic and exonic sequences are required, at least in
these cases, suggests that editing might occur cotranscrip-
tionally before introns are removed from the nascent tran-
script.
We have recently cloned two closely related variants of
 
Xenopus
 
 
 
laevis
 
 ADAR1 from an ovary cDNA library
 
(Brooks et al., 1998). The two cDNAs are, with the excep-
tion of a few exchanges, virtually identical to the two
cDNAs isolated by Bass and coworkers which were first
termed dsRAD-1 and dsRAD-2 but have since been
renamed ADAR1.1 and ADAR1.2, respectively (Hough
and Bass, 1997; Bass et al., 1997). Both proteins show a
high degree of sequence identity in their central and
COOH-terminal regions where they contain three dsRBDs
and a conserved deamination domain, respectively. How-
ever, at the NH
 
2
 
 terminus the two proteins show marked
differences. ADAR1.1 contains 14 repeats of an 11Ðamino
acids long sequence motif that is only present in one copy
in ADAR1.2 (see Fig. 1 a). ADAR1.1 is a protein of 1,270
amino acids whereas no proper AUG start codon has been
determined for ADAR1.2. However, Northern blots indi-
cate that both proteins are well expressed and seem to en-
code proteins of similar molecular mass (Hough and Bass,
1997).
To this point, no substrate RNAs for ADAR have been
identified in 
 
Xenopus
 
, although bFGF mRNA might be
edited by ADAR (Kimelman and Kirschner, 1989). How-
ever, the abundance of ADAR activity in 
 
Xenopus
 
 oo-
cytes and embryos suggests the presence of several sub-
strates for this enzyme. Furthermore, it has recently been
shown that mRNA levels of ADAR1 correlate with the
abundance of inosines present in cellular RNAs in various
rat tissues, suggesting the existence of further, yet to be
discovered ADAR1 substrates (Paul and Bass, 1998).
Therefore, we set out to study the intracellular localiza-
tion of 
 
Xenopus
 
 ADAR1.1 and ADAR1.2 in 
 
Xenopus
 
 oo-
cytes and on lampbrush chromosome spreads. We can
show that both forms of ADAR1 associate with the na-
scent RNP matrix on transcriptionally active chromosome
loops but also with a special loop.
 
Materials and Methods
 
Cloning of Xenopus ADAR1.1 and ADAR1.2
 
Part of a 
 
Xenopus
 
 ADAR1 cDNA was isolated from an expression screen
of a lambda Zap cDNA library for RNA-binding proteins (Jantsch and
Gall, 1992). Sequence analysis identified this cDNA as a homologue of
human ADAR1 from which the 5
 
9
 
 end was missing. Rescreening of a
cDNA library and 5
 
9
 
 RACE protocols resulted in the isolation of two vari-
ants of 
 
Xenopus
 
 ADAR1 that were identical to the previously published
 
Xenopus
 
 ADAR1.1 and ADAR1.2 sequences. Whereas ADAR1.1 had a
full-length open reading frame, ADAR1.2 had no AUG translational ini-
tiation codon. To allow expression of this clone, a self complementary oli-
gonucleotide (5
 
9
 
-CTA GCG TGT AAT GCA TTA CAC G-3
 
9
 
) was in-
serted in frame upstream of the cDNA in the SpeI restriction site of the
pBluescript polylinker.
 
Antibody Production
 
For antibody production a 564-bp long EcoRI fragment encoding amino
acids 373Ð561 in ADAR1.1 was cloned into pGEX 1 vector (Pharmacia)
from where the fragment was expressed as a glutathione S transferase
(GST) fusion protein in 
 
E
 
. 
 
coli
 
 BL21. The fusion protein was purified on
glutathione Sepharose beads (Pharmacia) according to the manufacturerÕs
protocol. Eluted fusion protein was at least 99% pure as judged on over-
loaded Coommassie stained gels. Fusion protein was dialyzed against
0.05% TFA in H
 
2
 
O and lyophilized. Two rabbits were immunized and
boosted in 4-wk intervals. Test sera were taken 2 wk after each injection.
After two booster injections antisera from both rabbits could recognize
endogenous ADAR1 on Western blots at which time point animals were
killed and all serum was collected. Antisera were produced by Euro-
gentec. 
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Myc-tagging of ADAR1.1 and ADAR1.2
 
ADAR1.1 was tagged with six tandemly arranged myc epitopes at either
the 5
 
9
 
 end the 3
 
9
 
 end or at both ends. To do this the 
 
z
 
250 bp long region
encoding the six myc tags was cloned in frame upstream, downstream or
at both ends of the ADAR1.1 cDNA. ADAR1.2 cDNA was only tagged
at its 3
 
9
 
 end. After insertion of the AUG start codon at the 5
 
9
 
 end of the
cDNA the myc-encoding sequence was cloned in frame downstream of
the ADAR1.2 cDNA sequence. Additionally, to stabilize in vitro synthe-
sized RNAs when injected into oocytes, the 3
 
9
 
 UTR including a poly(A)
 
1
 
tail of the 
 
Xenopus
 
 NO38 cDNA was cloned at the 3
 
9
 
 end of all tagged
ADAR variants (Peculis and Gall, 1992).
 
Construction of ADAR1.1 Deletions
 
Construct 
 
D
 
REP was made from a partial cDNA obtained from our origi-
nal phage screen. This construct deletes the first 250 codons of the
ADAR1.1 cDNA. 
 
D
 
REP was myc tagged at its COOH terminus and the
NO38 poly(A)
 
1 
 
tail was added at its 3
 
9
 
 end (Peculis and Gall, 1992). A self
complementary oligonucleotide containing an AUG codon was intro-
duced in-frame upstream of the cDNA in the SmaI site of the pBluescript
polylinker (5
 
9
 
-GAT GCA TC-3
 
9
 
).
Construct 
 
D
 
ZBD was made by digesting the ADAR1.1 clone contain-
ing a COOH-terminal myc-tag with NdeI and AvaI (partial). After polish-
ing the ends the DNA was religated. This construct deletes 363 codons
from the 5
 
9
 
 end of the ADAR1.1 cDNA. Translation starts at an internal
Met at codon 364.
 
Oocyte Injections
 
Myc-tagged ADAR1 variants were linearized at a unique restriction site
downstream of the NO38 poly(A)
 
1
 
 tail. Capped run off transcripts were
synthesized in vitro from the linearized templates using T3 RNA poly-
merase. Aliquots of all RNAs were checked for integrity on RNA gels by
ethidium bromide staining. Oocytes were injected with 50 ng RNA per
oocyte and incubated at 16
 
8
 
C for 48Ð72 h to allow protein synthesis to
occur.
25 to 50 ng of oligonucleotides anti-U2b (Pan and Prives, 1988) or unre-
lated oligonucleotides (M13-20 5
 
9
 
-GTAAAACGACGGCCAGT-3
 
9
 
, MJ
183 5
 
9
 
-ACGGAGGATCCAATGAGTGAAGAGGAGCA-3
 
9
 
) were in-
jected into the cytoplasm of oocytes. Inhibition of transcription could be
followed immediately by microscopic observation of lampbrush chromo-
some (LBC) preparations. Oocytes were subsequently incubated at 16
 
8
 
C
for 24 h after which time transcription resumed. For double injection ex-
periments with oligonucleotides and myc-tagged ADAR1.1 oocytes were
injected with the oligonucleotide 6 h before injection of the RNA.
Destruction of U2 snRNA was monitored by Northern blotting as de-
scribed (Tsvetkov et al., 1992).
 
Inhibition of Transcription
 
Transcription was inhibited either by oligonucleotide injection (see
above) or by incubation of oocytes in AMD or alpha-amanitin at concen-
trations of 50 
 
m
 
g/ml or 400 
 
m
 
g/ml, respectively, in OR2 medium (82.5 mM
NaCl, 2.5 mM KCl, 1 mM CaCl
 
2
 
, 1 mM MgCl
 
2
 
, 1 mM Na
 
2
 
HPO
 
4
 
, 5 mM
Hepes, pH 7.8). Oocytes were typically held for 12Ð24 h in the presence of
those inhibitors before they were used for chromosome preparations and
immunofluorescence staining. In some cases incubation was extended for
up to 5 d. Also, to ensure uptake of the drugs, some oocytes were injected
with AMD or alpha-amanitin stock solutions. In all cases transcription
seemed completely inhibited.
 
LBC Preparations and Immunofluorescence Stainings
 
LBC preparations and immunofluorescence stainings were performed as
described in Wu et al. (1991). For RNAse treatment, preparations were
digested after centrifugation but before fixation in paraformaldehyde with
a mixture of RNAse A (1 mg/ml) and RNAse T1 (10,000 U/ml) at 37
 
8
 
C
for 30 min. Subsequently, slides were washed in PBS and fixed for an addi-
tional hour in 2% paraformaldehyde in PBS before antibody staining. An-
tibodies used were Sat3 and Sat4 preimmune and immune sera, directed
against 
 
Xenopus
 
 ADAR1; mAb Y12, directed against the Sm core pro-
teins found on most splicing snRNPs (Lerner et al., 1981); mAb K121,
directed against the trimethyl guanosine cap present on most splicing
snRNAs (Krainer, 1988); mAb H14 and mAb CC3, directed against PolII
(Kim et al., 1997; Vincent et al., 1996); affinity-purified CBP20 antiserum
 
(Visa
 
 
 
et al., 1996); and mAb 9E10 directed against the myc tag (Evan et al.,
1985). For single immunofluorescence labeling primary antibodies were
detected with a secondary FITC-labeled antibody. For double labeling ex-
periments the rabbit polyclonal sera were detected with a rhodamine-
labeled secondary antibody while mouse mAbs were detected with a
FITC-labeled antibody. Pictures were taken on a Zeiss fluorescence mi-
croscope equipped with DIC on Kodak Tmax 100 film which was pushed
during development to 400 ASA.
 
Western Blots
 
For Western blots, oocytes were hand enucleated and nuclei (GVs) and
cytoplasms were collected separately. Typically five GVs and five cyto-
plasms were loaded per lane on a 7% SDS-PAGE. Gels were blotted to
Immobilon
 
 P 
 
membranes (Millipore, MA). Myc-tagged proteins were de-
tected with mAb 9E10 and an alkaline phosphatase labeled goat antiÐ
mouse antibody (Pierce) that was detected with the NBT-BCIP substrate.
Endogenous proteins were detected with Sat3 or Sat4 antisera at 1:600 di-
lutions followed by detection with 
 
125
 
I-labeled protein A (Amersham).
 
Results
 
Antibodies against ADAR1 Recognize both ADAR1.1 
and ADAR1.2
 
To study the intracellular distribution of 
 
Xenopus laevis
 
ADAR1 (xlADAR1), we generated antibodies against a
187Ðamino acid long fragment located in the NH
 
2
 
-terminal
region of the protein. The region chosen showed only few
amino acid exchanges between the conceptual translation
products of both ADAR1.1 and ADAR1.2. It was thus as-
sumed that both proteins would be recognized by antisera
directed against the fusion protein.
Two antisera termed Sat3 and Sat4 recognized the GST
fusion protein and were thus tested for their ability to de-
tect the endogenous protein in oocyte extracts.
Oocytes were hand enucleated and nuclei (GVs) and cy-
toplasms were probed by Western blotting with both Sat3
and Sat4 antisera. Both antisera showed virtually identical
results and detected a single band of 
 
z
 
125 kD in nuclei
while no signal could be detected in cytoplasmic lanes. A
single band of 
 
z
 
125 kD was also detected in XlA6 cells, a
 
Xenopus
 
 fibroblast tissue culture cell line (Fig. 1 b). Both
corresponding preimmune sera showed no signal (data
not shown). The detected band of 125 kD is slightly
smaller than the predicted molecular mass of 138 kD for
xlADAR1.1. However, purified xlADAR1 also migrates
with an apparent molecular mass of 120 kD (Hough and
Bass, 1994). Similarly, ADAR1 proteins from other spe-
cies also migrate faster than predicted from their amino
acid composition (OÕConnell et al., 1995). This anomalous
migration has been attributed to proteolytic degradation
at the NH
 
2
 
-terminal end of ADAR1 proteins, a phenome-
non also observed for xlADAR1 (see below; Patterson
and Samuel, 1995). The presence of ADAR1 in oocyte nu-
clei is in good agreement with previous findings that
showed that the enzyme is confined to the nucleus until
GV breakdown occurs (Bass and Weintraub, 1988).
To determine whether Sat3 and Sat4 antisera could de-
tect both ADAR1.1 and ADAR1.2 proteins we performed
immunoprecipitation experiments on oocytes that had
been injected with mRNAs encoding either ADAR1.1 or
ADAR1.2. Since ADAR1.2 lacks its own 5
 
9
 
 AUG codon
an oligonucleotide containing a suitable translational initi-
ation codon was cloned in frame at the 5
 
9
 
 end of the 
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cDNA. Furthermore, to distinguish endogenous from in-
jected ADAR1 proteins the cDNAs were fused in frame
with a 6
 
3
 
 myc-tag at both ends (ADAR1.1) or at the
COOH terminus only (ADAR1.2). Capped mRNAs en-
coding the resulting fusion proteins were in vitro tran-
scribed and injected into the cytoplasm of oocytes. After
overnight incubation, nuclei were hand isolated and used
for immunoprecipitation with Sat3 and Sat4 antibodies.
The immunoprecipitated material was then tested for the
presence of myc-tagged xlADAR1.1 or xlADAR1.2. Both
antisera were capable of immunoprecipitating either pro-
tein, indicating that both proteins are recognized by both
antisera (Fig. 1 c).
 
xlADAR1 Associates with the Nascent RNP Matrix and 
a Special Loop
 
xlADAR1 is a nuclear protein. Furthermore, in some
cases ADAR-mediated editing has been shown to require
the presence of both exonic and intronic sequences indi-
cating that this type of RNA editing might occur cotrans-
criptionally (Higuchi et al., 1993; Lomeli et al., 1994).
ADAR acts exclusively on double-stranded RNAs. The
interaction between ADAR and its double-stranded sub-
strate RNAs is most likely mediated by the three double-
stranded RNA-binding domains (dsRBDs) located in the
central part of the protein. However, it is not known how
substrate specificity is achieved as adenosines will be
converted to inosines in virtually any synthetic double-
stranded RNA when injected into oocytes (Bass and
Weintraub, 1987; Rebagliati and Melton, 1987). To test
whether ADAR1 might indeed act cotranscriptionally and
to determine whether ADAR1 might only associate with a
specific subset of RNAs, we performed immunofluores-
cence stainings of spread GV contents with our ADAR1
antisera.
Spread germinal vesicles or LBC preparations allow the
detailed observation of several nuclear structures at high
resolution in the conventional light microscope. First,
LBCs can be well observed with a nascent RNP matrix
emerging from the transcriptionally active loops which
themselves protrude from the condensed chromosomal
axes of the two paired, homologous chromosomes, termed
bivalents. Second, 
 
z
 
1,500 amplified nucleoli can be distin-
guished. Finally, two types of spherical structures can be
distinguished in spread 
 
Xenopus
 
 GVs which, based on
their association with snRNP components, have been
termed B and C snurposomes (Wu et al., 1991).
Staining of LBCs with both Sat3 or Sat4 antisera showed
an extraordinarily prominent signal on a single set of loops
located on bivalent no. 3. In addition, there was moderate
staining of all other loops. Preimmune sera, in contrast,
showed no chromosomal staining indicating that the sig-
nals were specific for xlADAR1 (Fig. 2, and data not
shown). Staining with Sat3 showed a weak background on
C snurposomes that was also observed in the correspond-
ing preimmune serum whereas staining with Sat4 showed
a weak background on nucleoli also observable in the cor-
responding preimmune serum. Those weak background
signals that were only observed at low dilutions of antisera
were thus considered as nonspecific background signals.
The staining of the brilliant loop was so intense that it
Figure 1. Xenopus ADAR1.1 and ADAR1.2 are recognized by
SAT antisera. (a) Schematic representation of myc-tagged Xeno-
pus ADAR1.1 and ADAR1.2 proteins. ADAR1.1 contains an
11Ðamino acid long peptide motif that is repeated 14 times (left
striped box). Both proteins contain a putative Z-DNA binding
domain (black box), three dsRBDs (right striped boxes) and a
catalytic deamination domain (light gray box). The positions of
two putative NLSs is indicated by asterisks. ADAR1.1 was myc-
tagged at the NH2 terminus, the COOH terminus or at both ends
while ADAR1.2 was only myc-tagged at its COOH terminus. An
AUG codon was introduced at the 59 end of the ADAR1.2
cDNA that was missing from our original cDNA clone. (b) West-
ern blots of oocyte nuclei (GV), cytoplasms (C), and XlA6 cells
(TC) detected with Sat3 or Sat4 antisera directed against part of
the ADAR1.1 protein. Both antisera recognize a nuclear protein
of 125 kD that can also be detected in tissue culture cells. The de-
tected band is smaller than the predicted molecular mass of
ADAR1.1 but correlates well with the reported molecular mass
of purified ADAR1.1 from Xenopus. 5 GVs and 5 cytoplasms
were loaded per lane. (c) Sat antisera can precipitate ADAR1.1
and ADAR1.2. Myc-tagged ADAR1.1 or ADAR1.2 was ex-
pressed in Xenopus oocytes. Oocyte extracts expressing either
ADAR protein were used for immunoprecipitation with Sat3 an-
tiserum (IS), preimmune serum (PI), or Sat4 antiserum (not
shown). The precipitated material was probed with mAb 9E10
for the presence of myc-tagged ADAR1. Both ADAR1.1 and
ADAR1.2 could be precipitated by Sat antiserum (IS) but not
by the corresponding preimmune serum (PI). Positions of myc-
tagged ADAR1.1 and ADAR1.2 are indicated by arrowheads.
myc-tagged ADAR1.1 can be detected in its full-length form
(185 kD) and in a smaller version (150 kD) which is probably a
proteolytic breakdown product. 
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could still be detected at antisera dilutions up to 1:3,000. In
contrast, for the majority of all other loops staining was
well visible at antisera dilutions of 1:500. Thus, it was hard
to take photographic pictures with both the brilliant loop
and the regular loops at good resolutions. Therefore, Fig. 2
shows images of bivalent no. 3 including the brilliantly la-
beling loop and images of other bivalents, showing the la-
bel observed on all other chromosome loops.
 
myc-EÐtagged ADAR1 Mimics the Distribution of 
Endogenous xlADAR1
 
To determine whether the observed antibody staining was
indeed specific for ADAR1, we wanted to determine the
localization of myc-tagged ADAR1.1. To do this, myc-
tagged ADAR1.1 was expressed in oocytes by mRNA in-
jection. The protein was well detectable on Western blots
24 h after injection of the mRNA. To obtain good in situ
staining, however, it was usually necessary to incubate oo-
cytes for at least 48 h at 16
 
8
 
C. As protein synthesis did not
increase dramatically after 24 h (as judged by Western
blots) we believe that the prolonged incubation was re-
quired to displace endogenous protein by the epitope-
tagged version. Staining with the mAb 9E10 directed
against the myc-tag revealed that the tagged protein colo-
calized with endogenous ADAR1. The majority of the
regular loops were clearly stained. In addition, the bril-
liantly labeling loop was also intensely decorated by the
myc-tagged protein, at least in most cases (Fig. 2). This
data indicates that ADAR1 indeed associates with the
RNP matrix found on most loops and occurs in high con-
centrations on a loop on bivalent no. 3.
As a further control, to show that the chromosomal
staining with both Sat3 and Sat4 antisera was specific for
ADAR1, we blocked both antisera with the fusion pro-
teins used to generate antibodies. This blocking eliminated
chromosomal staining almost completely, leaving only a
faint signal on the intensely labeling loops on bivalent no.
3. Thus, the observed signals reflect the localization of en-
dogenous ADAR1 (Fig. 3).
 
The Intensely Labeling Loop on Chromosome no. 3 Has 
Several Specific Features
 
The brilliantly labeling loop on bivalent no. 3 was not al-
ways labeled by the myc-tagged ADAR1 protein, even
when the majority of all other loops showed clear labeling
of the RNP matrix. Labeling of this special loop not only
varied with the animal used for oocyte injection but also
required more time to accumulate high amounts of myc-
tagged protein, indicating that ADAR1 turnover at this
particular loop is somewhat slower than on other loops.
Furthermore, this set of loops is also morphologically out-
standing as it represents the rare occurrence of a Òdouble
Figure 2. xlADAR1 local-
izes to the nascent RNP ma-
trix and is specifically en-
riched on a special loop on
bivalent no. 3. LBCs were
prepared from oocytes
expressing myc-tagged
ADAR1.1. (aÐd) Normal
LBC and (eÐf) bivalent no. 3.
(a and e) DIC image, (b and
f) DAPI staining, (c and g)
localization of endogenous
ADAR1 detected with SAT4
antiserum in the rhodamine
channel and (d and h) lo-
calization of myc-tagged
ADAR1.1 detected with
mAb 9E10 in the fluorescein
channel. Endogenous and ec-
topically expressed ADAR1
is localized to LBC loops. (g
and h) A special loop on
bivalent no. 3 is enriched for
endogenous (g) and ectopi-
cally expressed ADAR1 (h).
The special loop is marked
by arrows. Faint background
signals can be seen on nucle-
oli (N) or snurposomes (S)
by staining with SAT4 antise-
rum that is not seen with
myc-tagged ADAR1.1. Bar,
10  mm. 
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loop bridgeÓ where the chromosomal axis at the basis of
the loop is interrupted, giving the impression of bridging
two parts of a chromosomal axis by this loop. Therefore,
we set out to analyze the brilliantly labeling loop and the
regular loops showing ADAR1 staining in more detail.
First, we tested whether the observed labeling of all
loops was RNA dependent. Therefore, we treated LBC
preparations with RNAse before staining with Sat3 or
Sat4 antibodies. RNAse treatment clearly abolished all
chromosomal staining with anti-ADAR antibodies, indi-
cating that ADAR1 was indeed directly or indirectly asso-
ciated with RNA (Fig. 3). Next, we wanted to inhibit RNA
synthesis with the transcriptional inhibitors actinomycin D
(AMD) and 
 
a
 
-amanitin. AMD is a DNA-binding drug
that is a general inhibitor of transcription. 
 
a
 
-Amanitin, in
contrast, shows dose-dependent inhibition of transcrip-
tion. At low concentrations 
 
a
 
-amanitin is an efficient in-
hibitor of Pol-II while Pol-III is inhibited at higher concen-
trations. The two drugs were thus either added to the
medium or injected into oocytes at concentrations high
enough to inhibit all transcription. Oocytes treated this
way were used to prepare LBCs which were subsequently
stained with either Sat3 or Sat4 antibodies (Fig. 3).
An obvious sign for the inhibition of transcription is the
lack of transcriptionally active chromosome loops. Stain-
ing of these preparations with DAPI shows the chromo-
Figure 3. Localization of
ADAR1 to LBC loops is
RNA dependent. Staining of
bivalent no. 3 with SAT4 an-
tiserum. (a, d, g, j, and m)
DIC image, (b, e, h, k, and n)
DAPI staining, and (c, f, i, l,
and o) staining with Sat4
in the fluorescein channel.
(aÐc) ADAR1 is localized to
LBC loops and is specifically
enriched on a special loop.
(dÐf) Staining with Sat4 can
be blocked by ADAR1 pep-
tide. (f) SAT signal is almost
completely diminished when
the antiserum was blocked
with ADAR1 peptide origi-
nally used for the immuniza-
tion. (gÐi) SAT staining is
sensitive to RNAse treat-
ment. LBCs were digested
with RNAse before staining
with Sat4 antiserum. (g) The
loops appear ÒstrippedÓ after
RNAse treatment, and (i) no
signal can be observed in the
fluorescein channel. (jÐl)
Treatment with actinomycin
D inhibits transcription and
diminishes staining of regular
loops but not of the special
loop on bivalent no. 3. (j)
DIC image of bivalent no. 3
prepared from an oocyte af-
ter incubation in AMD. The
chromosomal axes is con-
densed and shows no tran-
scriptionally active loops.
Also nucleoli (N) change
their morphology. (k) The
condensed, shortened chro-
mosomal axes is well stained
with DAPI. The position of the special loop forming a Òdouble loop bridgeÓ is seen by the interrupted DAPI staining of the chromo-
somal axes on both homologues (arrowhead). (l) As transcription is inhibited no ADAR1 staining can be observed. Only the special
loop is still brilliantly labeled by SAT4 antiserum. (mÐo) Injection of an unrelated oligonucleotide temporarily inhibits transcription but
does not affect ADAR1 localization on the special loop on bivalent no. 3. (m) DIC image of bivalent no. 3 prepared from an oocyte
24 h after injection of an oligonucleotide. The presence of loops on the chromosome indicates that transcription has already resumed.
(n) DAPI image of the same region. (o) ADAR1 can be detected on most transcripts and on the special loop by staining with SAT4 an-
tiserum. Note: Shortly after injection of the oligo transcription seizes and no ADAR1 staining can be detected on regular loops (not
shown). However, staining of the brilliantly labeling loop is not affected by this treatment. Bars, 10 mm. 
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somes to be condensed and shortened. Furthermore, as
AMD also inhibits Pol-I the nucleoli show a changed
morphology and appear swollen. Consistent with the
lack of transcriptionally active loops, no staining of regu-
lar  loops was observed with either antiserum directed
against ADAR1. However, the brilliantly labeling loops
on bivalent no. 3 were still intensely labeled by Sat3 and
Sat4 antisera (Fig. 3). Remarkably, this staining persisted
even after 5 d of incubation in AMD or 
 
a
 
-amanitin.
Another possibility to inhibit transcription on LBCs is
the injection of oligonucleotides into the nucleus or cyto-
plasm of oocytes. Shortly after injection of the oligonucle-
otide transcription stops (Tsvetkov et al.,
 
 
 
1992). 12 to 24 h
after injection of the oligo transcription resumes produc-
ing large, transcriptionally active loops. Therefore, we
tested several unrelated oligonucleotides for their effect
on transcription and ADAR1 localization on regular loops
and on the brilliantly labeling loops. The outcome of these
experiments was similar to the ones obtained with chemi-
cal inhibitors of transcription. As all loops disappeared no
ADAR1 staining was observed on the regular chromo-
somal loops. However, the brilliantly labeling loop was
still clearly recognizable, both morphologically and by
staining with Sat3 or Sat4 antisera, indicating that the in-
jected oligonucleotide did not affect this special loop (data
not shown). After transcription resumed, normal staining
of most loops and the special loop on chromosome no. 3
could be seen (Fig. 3). Taken together, these data suggest
that whatever RNA is localized at this loop might not be
 
transcribed by a conventional polymerase, or, alterna-
tively, is not synthesized at this location.
To test the former possibility we performed double im-
munofluorescence staining with mAbs H14 or CC3, both
directed against Pol-II, and Sat4 antiserum (Vincent et al.,
1996; Kim et al., 1997). This data showed the presence of
Pol-II on all regular loops, as a faint line of signal could be
seen throughout the axis of loops. The brilliantly labeling
loops, in contrast, showed no detectable signal with either
mAb directed against Pol-II, suggesting that no Pol-II-depen-
dent transcription occurs at this particular loop (Fig. 4).
Most transcriptionally active loops are decorated with a
multitude of snRNP and hnRNP components. Interest-
ingly, all splicing components are present on the majority
of loops where they are distributed almost homogeneously
(Wu et al., 1991). However, several loops, so-called giant
loops, have been observed that lack those components
found on most other transcripts. Therefore, we tested
whether the brilliantly labeling loop on bivalent no. 3
might in fact represent such a loop by staining LBCs with
several antibodies directed against splicing and hnRNP
components. Among these was antibody K121, directed
against the 3mG cap present on most splicing snRNAs,
mAb Y12, directed against the Sm core proteins, the anti-SR
protein antibody SC35 and an antibody directed against
the cap binding protein CBP20 (Lerner et al., 1981;
Krainer, 1988; Fu and Maniatis, 1990; Visa
 
 
 
et al., 1996). All
those antibodies clearly labeled all regular loops but also
the brilliantly labeling loop on bivalent no. 3 which was
Figure 4. Double staining of
the special loop on bivalent
no. 3 with various antibodies
and SAT antiserum. (a, d,
g, and j) DIC images, (b, e,
h, and k) fluorescein channel,
and (c, f, i, and l) staining
with SAT4 antiserum in the
rhodamine channel. Arrows
mark the position of the spe-
cial loop. (aÐc) Staining with
mAbH14 (b) shows the pres-
ence of RNA Pol-II on all
regular loops as a fine signal
seen in the center of each
loop. However, Pol-II is ab-
sent from the special loop
which is brilliantly labeled by
SAT4 antiserum (c). (dÐf)
Staining with mAb K121 in-
dicates the presence of 3mG
snRNP cap structures on the
special loop (e) which is also
labeled with SAT4 antise-
rum (f). (gÐi) mAb Y12 stains
regular loops and the special
loop indicating the presence
of Sm proteins on the special
loop (h). (jÐl) The SR splicing
factor SC35 can also be found
on the special loop (k). Bar,
10 mm. 
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identified by double staining the preparations with Sat3
antiserum (Fig. 4, and data not shown). This indicates that,
despite the lack of detectable Pol-II on the special loop on
bivalent no. 3, the RNP matrix present there is associated
with all components typical for Pol-II transcripts.
 
Nuclear Splicing Is Not Required for
ADAR1 Localization
 
Editing sites in some mammalian substrate RNAs are de-
fined by short basepaired regions formed between exonic
and adjacent intronic sequences (Higuchi et al., 1993;
Lomeli et al., 1994; Herb et al., 1996; Burns et al., 1997).
This raises the possibility that RNA editing might be
linked to splicing, at least in timing if not mechanistically.
Thus, we tested whether inhibition of splicing influences
the association of ADAR1 with the RNP matrix on chro-
mosome loops. One would expect, for instance, if spliceo-
some formation is required for the association of ADAR
with RNA that inhibition of splicing might lead to an in-
creased or altered association of ADAR with the nascent
RNP matrix.
Therefore, an antisense oligonucleotide directed against
U2 snRNA was injected into oocytes which leads to de-
struction of U2 snRNA via RNAse H mediated cleavage
(Pan and Prives, 1988). Oocytes depleted of U2 snRNA
are defective in splicing. As mentioned, injection of any
oligonucleotide temporarily inhibits transcription in a non-
specific manner. However, after several hours normal
transcription resumes with the exception that U2 is miss-
ing from the loop matrix (Tsvetkov et al., 1992).
Destruction of U2 was monitored by Northern blotting
of RNAs isolated from individual GVs of injected and
control oocytes (data not shown). After transcription re-
sumed, LBCs were tested for the localization of ADAR1
by staining with Sat3 antiserum (Fig. 5). Interestingly, no
difference in ADAR1 localization could be observed in
U2 depleted oocytes, indicating that splicing and spliceo-
some formation is not required for the association of
ADAR1 with the nascent RNP matrix.
 
The NH
 
2
 
-terminal Peptide Repeats and a Putative
Z-DNA Binding Domain Are Not Required for 
Chromosomal Localization
 
Although ADAR1.1 and ADAR1.2 show a high degree
of sequence identity in their central region and at their
COOH termini, their NH2 termini differ considerably
(Hough and Bass, 1997). Part of this difference can be at-
tributed to the presence of an 11Ðamino acids long repeat
that is present in 14 almost perfect tandemly arranged cop-
ies in ADAR1.1 but only in a single copy in ADAR1.2. To
test whether these peptide repeats are required for proper
association of ADAR1 with the RNP matrix we have ana-
lyzed the nuclear distribution of myc-tagged ADAR1.2
and ADAR1.1 from which the NH2-terminal end includ-
ing the peptide repeats had been removed (construct
DREP, Fig. 7). When compared for their in situ localiza-
tion on Xenopus LBCs, both clones showed an identical
distribution: Strong labeling of the special loop was ob-
served whereas moderate labeling was detectable on all
other loops (Fig. 6). This indicates that the peptide repeats
have no influence on the intranuclear association of
ADAR1 with chromosome loops.
The 11Ðamino acid long peptide repeats are followed by
a 70Ðamino acid long region that is highly conserved
among all ADAR1 isoforms from various species includ-
ing Xenopus ADAR1.1 and ADAR1.2. This sequence
motif isolated from human ADAR1 has been shown to
bind Z-DNA in vitro and has thus been suggested to be re-
quired for the localization of ADAR1 to transcriptionally
active DNA that would facilitate the association of the
protein with nascent transcripts (Herbert et al., 1997). To
test this hypothesis, we constructed a myc-tagged version
of Xenopus ADAR1 from which the entire NH2-terminal
end including the putative Z-DNA binding region had
been deleted (construct DZBD, Fig. 7). In situ, this dele-
tion variant localized like wild-type ADAR1 indicating
that the Z-DNA binding activity is not required for the re-
cruitment of the protein to actively transcribing chromo-
some loops (Fig. 6).
Figure 5. Splicing is not re-
quired for ADAR1 localiza-
tion. (a and d) DIC images,
(b and e) DAPI staining, and
(c and f) ADAR1 localiza-
tion detected by staining with
SAT4 antiserum in the fluo-
rescein channel. (aÐc) Stain-
ing of bivalent no. 3 from an
untreated oocyte shows local-
ization of ADAR1 on the
RNP matrix of regular loops
and on the special loop. (dÐf)
24 h after injection of the
U2b oligo transcription has
resumed giving rise to promi-
nent loops (d). (f) Staining
with SAT4 antiserum shows
the presence of ADAR1 on
the loop matrix and on the
special loop on bivalent no. 3.
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Interestingly, this deletion variant also removes one of
two putative nuclear localization signals from the predicted
protein sequence (Hough and Bass, 1997). However, West-
ern blots of oocytes injected with this construct still showed
clear nuclear accumulation of the protein (Fig. 7). As this
deletion still localizes to chromosomes and enters the nu-
cleus we can conclude that this first NLS sequence located
between amino acids 291 and 307 in ADAR1 is not re-
quired for nuclear localization of the protein.
ADAR1 Undergoes NH2-terminal Proteolytic Cleavage
ADAR1 protein purified from endogenous sources of
various species is smaller than the calculated molecular
mass predicted from the corresponding cloned cDNA se-
quences (Hough and Bass, 1994, 1997; Kim et al., 1994;
Patterson and Samuel, 1995). This obvious discrepancy
has been attributed to a proteolytic cleavage at the NH2-
terminal end of the protein. It has to be noted, however,
that the smaller purified protein is enzymatically active in-
dicating that the proposed cleavage does not influence en-
zyme activity (for review see Bass, 1997).
In the course of our experiments we have used
ADAR1.1 variants that were epitope-tagged at their NH2
terminus, COOH terminus or at both ends. Western blots
of oocyte extracts that had been injected with any of those
constructs confirmed the proposed cleavage of ADAR1.1
at its NH2 terminus: oocytes injected with the NH2-termi-
nally tagged construct showed a signal at 180 kD which
was relatively faint. In contrast, oocytes injected with
ADAR1.1 tagged at its COOH terminus or at both ends
showed a much smaller signal of z130 kD that was much
stronger than the signal obtained from the NH2-terminally
tagged protein. Additionally, the latter constructs showed
faint bands of 180 and 185 kD, respectively, representing
the full-length protein (Fig. 7). This finding is fully com-
patible with the proposed proteolytic cleavage in the NH2-
terminal region of the protein. In the case of the NH2-ter-
Figure 6. In situ localization
of ADAR1.2 and ADAR1.1
deletions. (a, e, and i) DIC
image, (b, f, and j) DAPI
staining, (c, g, and k) localiza-
tion of myc-tagged ADAR1
variants as seen in the fluo-
rescein channel, and (d, h, l)
localization of endogenous
ADAR1 as seen after stain-
ing with SAT4 antiserum in
the rhodamine channel. (aÐd)
myc-tagged ADAR1.2 local-
izes like ADAR1.1 to regular
loops and to the special loop
on bivalent no. 3. (c) the lo-
calization of myc-tagged
ADAR1.2 and (d) endoge-
nous protein is virtually iden-
tical. (eÐh) The NH2-terminal
peptide repeats found in
ADAR1.1 are not required
for localization of the pro-
tein. (g) myc-tagged DREP
construct localizes to nascent
transcripts and to the special
loop on bivalent no. 3. (iÐl)
Construct  DZBD, deleting
the NH2-terminal end of
ADAR1.1 including a puta-
tive Z-DNA binding domain
and one putative NLS, shows
wild-type-like in situ localiza-
tion. (k) myc-tagged DZBD
construct (l) counterstain-
ing with Sat4 antiserum.
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minally tagged construct we can only detect the full-length
construct as the cleaved protein looses its tag. Since most
of the protein is cleaved, the signal derived from this con-
struct is relatively weak. The COOH-terminally tagged
construct, in contrast, can be detected in its full-length and
cleaved version, giving rise to the two bands detected in
Western blots. As the majority of the protein is cleaved
the larger band is much fainter than the lower band.
To confirm these results we have also performed West-
ern blots of oocytes injected with the mentioned tagged
constructs on high percentage gels. As expected, the small
NH2-terminal cleavage product of z25 kD can only be ob-
served in oocytes injected with ADAR proteins tagged at
their NH2-terminal end or at both ends (data not shown).
It should also be noted, that cleaved and uncleaved
products could be detected both in the cytoplasm and the
nucleus and that all tagged versions showed normal intra-
nuclear distribution, indicating that the cleavage has no in-
fluence on the nuclear and intranuclear localization of
ADAR1.1 (Fig. 7).
Discussion
Editing by ADAR-like enzymes can be unspecific and af-
fect many adenosine residues in a double-stranded region
but can also be very specific as in the case of GluR-B
mRNA where three adenosines are preferentially modi-
fied by ADAR1 or ADAR2 (Hurst et al., 1995; Dabiri et
al., 1996; Melcher et al., 1996). Currently, it is not known
how substrate specificity of ADAR1 is achieved. It could
be, for instance, that the three dsRBDs of ADAR1 are
solely responsible for substrate recognition. This view
is supported by the finding that purified ADAR1 and
ADAR2 can edit GluR-B pre-mRNA quite specifically
without additional cofactors being required (Hurst et al.,
1995; Dabiri et al., 1996; Melcher et al., 1996). Alterna-
tively, substrate specificity could be mediated by the for-
mation of a complex containing ADARs and other RNA-
interacting proteins. However, since such complexes have
not yet been reported this model is only speculative. Fi-
nally, the deaminase domain might discriminate among
different substrates, a view supported by recent data on
Tad1p a tRNA-specific adenosine deaminase lacking any
dsRBDs (Gerber et al., 1998).
ADAR1 Localization on Transcriptionally Active 
Chromosome Loops
We have shown that both endogenous and myc-tagged Xe-
nopus ADAR1 are associated with the RNP matrix on
LBC loops and specifically localizes to a special loop. Sev-
eral conclusions can be drawn from this observation. First,
ADAR1 mediated editing can, in principle, take place
cotranscriptionally as the enzyme associates with the na-
scent RNP matrix before transcription is completed. This
is particularly interesting when considering that intronic
sequences define ADAR editing sites in GluR-B and sero-
tonin 2C receptor mRNAs (Higuchi et al., 1993; Lomeli
et al., 1994; Herb et al., 1996; Burns et al., 1997). Splicing is
a cotranscriptional process as well (Beyer and Osheim,
1988; Baurn and Wieslander, 1994). In fact, the entire
splicing machinery can be found associated with most
Figure 7. (a) Schematic representation of deletion constructs
used in this study. The peptide repeats (left striped box), the
ZBD (black box), the dsRBDs (right striped box) and the deami-
nation domain (gray box) are indicated. DREP deletes the NH2-
terminal peptide repeats from ADAR1.1 leaving a single,
COOH-terminal myc tag. DZBD deletes a longer portion from
the NH2 terminus of ADAR1.1 including the putative Z-DNA
binding domain and one of two putative NLSs. ADAR1.2 does
not contain the peptide repeats and is only myc-tagged at its
COOH terminus. An artificial AUG codon was introduced at the
beginning of the cDNA. (b) Western blot of oocyte nuclei (GV)
and cytoplasms (Cytopl.) of uninjected oocytes (2) and of oo-
cytes expressing myc-tagged ADAR1 versions. All myc-tagged
ADAR1 versions express well and accumulate in the nucleus.
Cytoplasmic signals are seen 24 h after injection but diminish
over time as the protein is transported to the nucleus. (c)
ADAR1 undergoes NH2-terminal proteolytic cleavage. Western
blot of oocyte nuclei (GV) and cytoplasms (Cytopl.) of unin-
jected (2) or injected oocytes expressing ADAR1.1 myc tagged
at its COOH terminus (C), COOH and NH2 terminus (NC) or
NH2 terminus only (N). In the cytoplasm full-length versions (180
to 190 kD) of all three constructs can be easily detected (upper
two arrowheads). A smaller (150 kD) breakdown product can
only be detected for the two versions carrying a COOH-terminal
myc-tag (lower arrowhead). In the nucleus (GV) the breakdown
product is the most prominent form found 24 h after injection.
However, also the full-length versions can be detected in the nu-
cleus. If the myc-tag is only present at the NH2 terminus (N) only
full-length protein can be detected, indicating that the NH2 ter-
minus undergoes proteolytic cleavage.Eckmann and Jantsch ADAR1 Localization on Xenopus Lampbrush Chromosomes 613
chromosome loops in Xenopus and Notophthalmus GVs
showing a distribution similar to ADAR1 (Wu et al.,
1991). Taken together, this leaves the possibility that edit-
ing substrates in Xenopus could also be defined by base-
paired regions of intronic and exonic sequences. In fact, if
editing takes place cotranscriptionally it could even be
regulated by the rate of splicing.
However, oocytes depleted of their endogenous U2 sn-
RNA showed a normal localization of endogenous and
myc-tagged ADAR1, indicating that inhibition of splicing
does not affect the enzymeÕs association with the RNP ma-
trix. In this context, it is interesting to note that injection of
anti-U2 oligonucleotides, just like injection of any other oli-
gonucleotide, temporarily inhibits transcription leading to
removal of the RNP matrix from the chromosome loops
(with the exception of the special loop on bivalent no. 3, see
below; Tsvetkov et al., 1992). After several hours, transcrip-
tion resumes leading to well observable transcriptionally ac-
tive chromosome loops. Therefore, the entire RNP matrix
visible on those loops has to be assembled de novo, includ-
ing ADAR1. We can thus conclude that ADAR1 assembly
with hnRNAs does not require spliceosome formation.
The widespread distribution of ADAR1 on LBCs sug-
gests that the enzymeÕs localization is not restricted to sites
where substrate RNAs are being transcribed but indicates
a substrate independent assembly of ADAR with the RNP
matrix. No editing substrates for ADAR1 have been iso-
lated from Xenopus. Nonetheless, as RNA editing is a rare
process it is hard to imagine that all loops being associated
with ADAR1 encode substrate RNAs. The general associ-
ation of ADAR1 with chromosome loops therefore sug-
gests that ADAR1-mediated editing is not regulated by
the association of ADAR1 with the RNP matrix. Instead,
other factors such as conformation or accessibility of the
underlying RNA, or interaction with other protein compo-
nents might regulate editing. However, in vitro editing re-
actions indicate that ADAR1 shows site-specific editing
without the need for further cofactors (Hurst et al., 1995;
Dabiri et al., 1996).
The mechanism by which ADAR1 associates with the
RNP matrix is not yet clear. Not all underlying hnRNAs
might contain sufficient double-stranded structures to pro-
vide binding sites for the dsRBDs. Therefore, ADAR1
might associate with the RNP matrix as part of a multipro-
tein complex. Such a situation has been found for Xlrbpa,
a protein exclusively consisting of three dsRBDs. Xlrbpa
is associated with hnRNAs as part of an hnRNP com-
plex (Eckmann and Jantsch, 1997). Similarly, hnRNP pro-
teins might facilitate the interaction of ADAR1 with the
RNP matrix. Nonetheless, at this point an interaction of
ADAR1 with hnRNP proteins remains to be determined.
It should be noted, however, that deletion of an individual
dsRBD from ADAR1 prevents chromosomal localization
of the protein, underscoring the importance of the RNA
binding domains for proper targeting of the protein (C.
Eckmann and M. Jantsch, manuscript in preparation).
The Special Loop on Bivalent no. 3
ADAR1 was not only found on the majority of regular
loops but was specifically enriched on a particular loop on
bivalent no. 3. The concentration of ADAR1 on this loop
was several-fold higher than on other loops. This finding
can be interpreted in several ways. On the one hand more
RNAs might be present on this special loop than on any
other loop. Alternatively, the RNAs on the special loop
could contain more binding sites for ADAR1. A third pos-
sibility would be that ADAR1 is localized to that loop as
pure protein or a multiprotein complex without RNA.
Protein storage loops have been demonstrated on the
LBCs of Drosophila hydei (Hulsebos et al., 1984). How-
ever, the sensitivity of the loops on bivalent no. 3 to
RNAse digestion clearly demonstrates that RNAs are
present and required for the localization of ADAR1 to the
special loops.
However, several features of the special loop are un-
usual. First, the loop represents the rare case of a so-called
double loop bridge where the condensed chromosomal
axes is disrupted only held together by the two loops
formed from each chromatid on each of the two homolo-
gous chromosomes (Callan, 1986). Second, the special
loops differ morphologically when compared with regular
loops. They appear somewhat smoother in texture and are
more diffracting when observed by phase contrast micros-
copy. Finally, and most important the special loops do not
stain with antibodies directed against RNA Pol-II and are
insensitive to treatment with inhibitors of known RNA
polymerases including injection of oligonucleotides.
These data suggest that the RNAs present on the special
loops might either be synthesized by a novel, unconven-
tional RNA polymerase or, alternatively, might not be
synthesized there but only stored or edited at that particu-
lar site.
While the first possibility appears rather unlikely, sev-
eral arguments make us favor the latter hypothesis. First,
our double staining experiments indicate that the compo-
sition of the RNP matrix on the special loops resembles
that of other Pol-II derived hnRNPs as they contain Sm
proteins, trimethyl guanosine caps, cap binding protein
CBP20 and accessory splicing factors such as SC35. It is
thus conceivable that a Pol-II transcript is made some-
where else and then transported to that particular loop
where it is found associated with ADAR1, possibly to be
edited. Such a scenario would also explain why ADAR1
localization to this loop is sensitive to RNAse digestion
but not to inhibition of transcription. The hypothesis is
also consistent with our finding that localization of
ADAR1 to this loop is not always observed and typically
requires more time than localization to the normal
loops.  Transport of a transcript made on a regular loop to
the special loop on bivalent no. 3 would certainly take
more time than association of a primary transcript with
myc-tagged ADAR1 would require. In this respect, the
ADAR1-positive loops resemble the so-called sequen-
tially labeling loops (SLL) described in urodeles. The hall-
mark of SLLs is their failure to incorporate 3H-labeled
ribonucleosides at a fast rate and the nonhomogeneous
distribution of label along the loop (Callan, 1986). Regular
loops incorporate label homogeneously over their entire
length, within an hour or so, at all sites where transcription
is taking place. SLLs, instead, incorporate 3H-labeled ribo-
nucleosides very slowly beginning from the thin end of the
loop axes. Over a period of several days incorporation of
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pushed forward from the thin end always leaving a sharp
margin between the labeled and unlabeled part of the loop
(Callan, 1986). It has thus been suggested that SLLs do not
represent sites of RNA synthesis but instead become la-
beled by associating with transcripts made at other sites
(Callan, 1986). Therefore, it seems conceivable that the
ADAR1 positive loop on bivalent no. 3 represents such a
SLL which accumulates transcripts synthesized elsewhere,
possibly for ADAR1 mediated editing. However, further
time course experiments with both 3H-labeled nucleosides
and myc-tagged ADAR1 will be required to clarify this
point.
The Variable NH2 Terminus of ADAR1
The NH2-terminal end of ADAR1.1 contains an 11Ðamino
acid long peptide repeat followed by a 70Ðamino acid long
region which, in human ADAR1, has been shown to bind
Z-DNA in vitro (Herbert et al., 1997). It has thus been
suggested that Z-DNA binding might be required to target
the enzyme to sites of transcription where Z-DNA confor-
mation is frequently observed. Targeting the enzyme to
sites of transcription by this means could then facilitate the
enzymeÕs association with nascent RNAs and thus help to
target newly transcribed RNAs. Our comparison of myc-
tagged ADAR1.1 and ADAR1.2, and of a deletion variant
lacking the putative Z-DNA binding motif clearly showed
that neither the 11Ðamino acid long peptide motif nor the
Z-DNA binding region is required for targeting of the en-
zyme to chromosome loops. All three constructs localized
to both regular loops and to the brilliantly labeling loop on
bivalent no. 3. It thus seems as if the two naturally occur-
ring variants of ADAR1 have similar if not equal func-
tions. The repeated, 11Ðamino acid long peptide motif has
so far only been found in ADAR1.1 of Xenopus and might
thus represent a peculiar gene only found in this pseudo-
tetraploid species.
However, while we could show that the Z-DNA binding
domain is not required for ADAR1 association with the
nascent RNP matrix we cannot exclude that this domain is
required for enzyme function in vivo. Further studies to
dissect the regions required for chromosomal localization
and enzyme function of Xenopus ADAR1 are currently in
progress.
We would like to thank Andrea Neunteufl and Lydia Pfaffstetter for ex-
cellent technical assistance. We thank Ian Mattaj for U-snRNA probes
and CBP-20 antibodies, Steven Warren for mAbH14 and Michel Vincent
for mAb CC3. We are especially grateful to Joe Gall for his help in identi-
fying individual chromosomes and for critical review of this manuscript.
This work was supported by Austrian Science Foundation grant no.
11444.
Received for publication 22 June 1998 and in revised form 11 January
1999.
References
Bass, B.L. 1997. RNA-editing and hypermutation by adenosine deamination.
Trends Biochem. Sci. 22:157Ð162.
Bass, B.L., and H. Weintraub. 1987. A developmentally regulated activity that
unwinds RNA duplexes. Cell. 48:607Ð613.
Bass, B.L., and H. Weintraub. 1988. An unwinding activity that covalently mod-
ifies its double-stranded RNA substrate. Cell. 55:1089Ð1098.
Bass, B.L., K. Nishikura, W. Keller, P.H. Seeburg, R.B. Emeson, M.A. OÕCon-
nell, C.E. Samuel, and A. Herbert. 1997. A standardized nomenclature for
adenosine deaminases that act on RNA. RNA. 3:947Ð949.
Baurn, G., and L. Wieslander. 1994. Splicing of Balbiani ring 1 gene pre-
mRNA occurs simultaneously with transcription. Cell. 76:183Ð192.
Beyer, A.L., and Y.N. Osheim. 1988. Splice site selection, rate of splicing, and
alternative splicing on nascent transcripts. Genes Dev. 2:754Ð765.
Brooks, R., C.R. Eckmann, and M.F. Jantsch. 1998. The double-stranded RNA-
binding domains of Xenopus laevis ADAR1 exhibit different RNA-binding
behaviors. FEBS Lett. 434:121Ð126.
Burns, C.M., H. Chu, S.M. Rueter, L.K. Hutchinson, H. Canton, E. Sanders-
Bush, and R.B. Emeson. 1997. Regulation of serotonin-2C receptor G-pro-
tein coupling by RNA editing. Nature. 387:303Ð308.
Callan, H.G. 1986. Lampbrush chromosomes. M. Solioz, editor. Springer Ver-
lag. Berlin.
Cattaneo, R., A. Schmid, D. Eschle, K. Baczko, V. ter Meulen, and M.A. Bil-
leter. 1988. Biased hypermutation and other genetic changes in defective
measles viruses in human brain infections. Cell. 55:255Ð265.
Dabiri, G.A., F. Lai, R.A. Drakas, and K. Nishikura. 1996. Editing of the GluR-B
ion channel RNA in vitro by recombinant double-stranded RNA adenosine
deaminase. EMBO (Eur. Mol. Biol. Organ.) J. 15:34Ð45.
Eckmann, C.R., and M.F. Jantsch. 1997. Xlrbpa, a double-stranded RNA-bind-
ing protein associated with ribosomes and hnRNAs. J. Cell Biol. 138:239Ð253.
Evan, G., G. Lewis, G. Ramsay, and M. Bishop. 1985. Isolation of monoclonal
antibodies specific for human c-myc proto-oncogene product. Mol. Cell.
Biol.  5:3610Ð3636.
Fu, X.D., and T. Maniatis. 1990. Factor required for mammalian spliceosome
assembly is localized to discrete regions in the nucleus. Nature. 343:437Ð441.
Gerber, A., H. Grosjean, T. Melcher, and W. Keller. 1998. Tad1p, a yeast
tRNA-specific adenosine deaminase, is related to the mammalian pre-
mRNA editing enzymes ADAR1 and ADAR2. EMBO (Eur. Mol. Biol. Or-
gan.) J. 17:4780Ð4789.
Herb, A., M. Higuchi, R. Sprengel, and P.H. Seeburg. 1996. Q/R site editing in
kainate receptor GluR5 an GluR6 pre-mRNAs requires distant intronic se-
quences. Proc. Natl. Acad. Sci. USA. 93:1875Ð1880.
Herbert, A., J. Alfken, Y.-G. Kim, I.S. Mian, K. Nishikura, and A. Rich. 1997.
A Z-DNA binding domain present in the human editing enzyme, double-
stranded RNA adenosine deaminase. Proc. Natl. Acad. Sci. USA. 94:8421Ð
8426.
Higuchi, M., F.N. Single, M. Khler, B. Sommer, R. Sprengel, and P.H. See-
burg. 1993. RNA editing of AMPA receptor subunit GluR-B: a base-paired
exon-intron structure determines position and efficiency. Cell. 75:1361Ð1370.
Hough, R.F., and B.L. Bass. 1994. Purification of the Xenopus laevis double-
stranded RNA adenosine deaminase. J. Biol. Chem. 269:9933Ð9939.
Hough, R.F., and B.L. Bass. 1997. Analysis of Xenopus dsRNA adenosine de-
aminase cDNAs reveals similarities to DNA methyltransferases. RNA.
3:356Ð370.
Hulsebos, T.J., J.H. Hackstein, and W. Hennig. 1984. Lampbrush loop-specific
protein of Drosophila hydei. Proc. Natl. Acad. Sci. USA. 81:3404Ð3408.
Hurst, S.R., R.F. Hough, P.J. Aruscavage, and B.L. Bass. 1995. Deamination of
mammalian glutamate receptor RNA by Xenopus dsRNA adenosine deami-
nase: similarities to in vivo RNA editing. RNA. 1:1051Ð1060.
Jantsch, M.F., and J.G. Gall. 1992. Assembly and localization of the U1-specific
snRNP C protein in the amphibian oocyte. J. Cell Biol. 119:1037Ð1046.
Kim, U., Y. Wang, T. Sanford, and K. Nishikura. 1994. Molecular cloning of
cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme
for nuclear RNA editing. Proc. Natl. Acad. Sci. USA. 91:11457Ð11461.
Kim, E., L. Du, D.B. Bregman, and S.L. Warren. 1997. Splicing factors associ-
ate with hyperphosphorylated RNA polymerase II in the absence of pre-
mRNA. J. Cell Biol. 136:19Ð28.
Kimelman, D., and M.W. Kirschner. 1989. An antisense mRNA directs the co-
valent modification of the transcript encoding fibroblast growth factor in Xe-
nopus oocytes. Cell. 59:687Ð696.
Krainer, A. 1988. Pre-mRNA splicing by complementation with purified hu-
man U1, U2, U4/U6 and U5 snRNPs. Nucleic Acids Res. 16:9415Ð9429.
Lerner, E.A., M.R. Lerner, C.A. Janeway, and J.A. Steitz. 1981. Monoclonal
antibodies to nucleic acid-containing cellular constituents: Probes for molec-
ular biology and autoimmune disease. Proc. Natl. Acad. Sci. USA. 78:2737Ð
2741.
Lomeli, H., J. Mosbacher, T. Melcher, T. Hger, J.R.P. Geiger, T. Kuner, H.
Monyer, M. Higuchi, A. Bach, and P.H. Seeburg. 1994. Control of kinetic
properties of AMPA receptor channels by nuclear RNA editing. Science.
266:1709Ð1713.
Melcher, T., S. Maas, A. Herb, R. Sprengel, P.H. Seeburg, and M. Higuchi.
1996. A mammalian RNA editing enzyme. Nature. 379:460Ð464.
OÕConnell, M.A. 1997. RNA editing: rewriting receptors. Curr. Biol. 7:R437Ð439.
OÕConnell, M.A., S. Krause, M. Higuchi, J.J. Hsuan, N.F. Totty, A. Jenny, and
W. Keller. 1995. Cloning of cDNAs encoding mammalian double-stranded
RNA-specific adenosine deaminase. Mol. Cell. Biol. 15:5376Ð5388.
OÕConnell, M.A., A. Gerber, and W. Keller. 1997. Purification of human dou-
ble-stranded RNA-specific editase 1 (hRED1) involved in editing of brain
glutamate receptor B pre-mRNA. J. Biol. Chem. 272:473Ð478.
Pan, Z.-Q., and C. Prives. 1988. Assembly of functional U1 and U2 human-
amphibian hybrid snRNPs in Xenopus laevis oocytes. Science. 241:1328Ð1331.
Patterson, J.B., and C.E. Samuel. 1995. Expression and regulation by interferon
of a double-stranded RNA-specific adenosine deaminase from human cells:
evidence for two forms of the deaminase. Mol. Cell. Biol. 15:5376Ð5388.
Paul, M.S., and B.L. Bass. 1998. Inosine exists in mRNA at tissue-specific levelsEckmann and Jantsch ADAR1 Localization on Xenopus Lampbrush Chromosomes 615
and is most abundant in brain mRNA. EMBO (Eur. Mol. Biol. Organ.) J. 17:
1120Ð1127.
Peculis, B.A., and J.G. Gall. 1992. Localization of the nucleolar protein NO38
in amphibian oocytes. J. Cell Biol. 116:1Ð14.
Petschek, J.P., M.R. Scheckelhoff, M.J. Mermer, and J.C. Vaughn. 1997. RNA
editing and alternative splicing generate mRNA transcript diversity for the
Drosophila 4f-rnp locus. Gene. 204:267Ð276.
Polson, A.G., and B.L. Bass. 1994. Preferential selection of adenosines for mod-
ification by double-stranded RNA adenosine deaminase. EMBO (Eur. Mol.
Biol. Organ.) J. 13:5701Ð5711.
Polson, A.G., B.L. Bass, and J.L. Casey. 1996. RNA editing of hepatitis delta vi-
rus antigenome by dsRNA adenosine deaminase. Nature. 380:454Ð456.
Polson, A.G., P.F. Crain, S.C. Pomerantz, J.A. McCloskey, and B.L. Bass. 1991.
The mechanism of adenosine to inosine conversion by the double-stranded
RNA unwinding/modifying activity: a high performance liquid chromatogra-
phy-mass spectrometry analysis. Biochemistry. 30:11507Ð11514.
Rebagliati, M.R., and D.A. Melton. 1987. Antisense RNA injections into fertil-
ized frog eggs reveal an RNA duplex unwinding activity. Cell. 48:599Ð605.
Sommer, B., M. Khler, R. Sprengel, and P.H. Seeburg. 1991. RNA editing in
brain controls a determinant of ion flow in glutamate-gated channels. Cell.
67:11Ð19.
St Johnston, D., N.H. Brown, J.G. Gall, and M. Jantsch. 1992. A conserved dou-
ble-stranded RNA-binding domain. Proc. Natl. Acad. Sci. USA. 89:10979Ð
10983.
Tsvetkov, A., M. Jantsch, Z. Wu, C. Murphy, and J.G. Gall. 1992. Transcription
on lampbrush chromosome loops in the absence of U2 snRNA. Mol. Biol.
Cell. 3:249Ð261.
Vincent, M., P. Lauriault, M.-F. Dubois, S. Lavoie, O. Bensaude, and B.
Chabot. 1996. The nuclear matrix protein p255 is a highly phosphorylated
form of RNA polymerase II largest subunit which associates with spliceo-
somes. Nucleic Acids Res. 24:4649Ð4652.
Visa, N., E. Izaurralde, J. Ferreira, B. Daneholt, and I.W. Mattaj. 1996. A nu-
clear cap-binding complex binds Balbiani ring pre-mRNA cotranscription-
ally and accompanies the ribonucleoprotein particle during nuclear export.
J. Cell Biol. 133:5Ð14.
Wu, Z., C. Murphy, H.G. Callan, and J.G. Gall. 1991. Small nuclear ribonucle-
oproteins and heterogeneous nuclear ribonucleoproteins in the amphibian
germinal vesicle: loops, spheres and snurposomes. J. Cell Biol. 113:465Ð483.
Yang, J.-H., P. Sklar, R. Axel, and T. Maniatis. 1995. Editing of glutamate re-
ceptor subunit B pre-mRNA in vitro by site-specific deamination of adeno-
sines. Nature. 374:77Ð81.